CollTech

CollTech Australia Limited (ASX: CAU) is an Australian public listed bio-industrial company specialising in the development and commercialisation of ovine collagen and collagen-based healthcare products. The company is committed to establishing its biomaterials division as a leading global supplier of high quality collagen and to building strategic alliances to develop and commercialise collagen-based cosmetic and medical products that advance healthcare. It markets these products in more than 15 countries. It also provides treated sheep pelts for a food grade collagen. In July 2009, the Company announced the acquisition of Holista Biotech Sdn Bhd.

Holista Biotech group of companies is a Biotech and Bionexus company with leading brands, namely PRISTIN™ fish oil, LACTO-5™ Probiotics, BONEX™ and a range of healthcare products. In line with the government’s aspirations in biotechnology, the company was awarded Bionexus status and several grants in 2007. We are firmly established in the Biotech industry through our strength and focus on investment in the research and development of innovative new products and patents. With the Group’s robust growth and continuing profitability of the Company, Holista is geared for public listing on the Board of Bursa Malaysia in 2009.


www.colltech.com.auwww.holistabio.com


HOW
MERCATUS
HELPED
 
Mercatus had helped its fund-raising by underwriting Colltech’s new share placement and rights issue. In addition, Mercatus had taken the initiative to identify commercial organizations outside of Australia for negotiation of business collaboration. Identified a business partner Holista who has knowledge of the business of collagens and could take it to markets that were not accessible to Colltech. This merger organized by Mercatus has been approved by ASX.

COPYRIGHT © 2010 MERCATUS CAPITAL